Alexa Chronister

Associate

Washington, D.C.

Alexa’s experience includes working on a range of health care and regulatory matters. She has assisted on matters for pharmacy, private equity, medical equipment, and health insurance clients.

Credentials

Education

  • Duke University School of Law, 2024, J.D., Duke Law Journal Staff Editor, Margolis Scholar at Duke-Margolis Center for Health Policy
  • University of Delaware, 2020, B.S., Phi Beta Kappa

Professional admissions & qualifications

  • District of Columbia

Insights

Insights
American University Washington College of Law Health Law & Policy Brief – Volume 18, Issue 2

Increasing Globalization of Pharmaceutical Clinical Trials: Benefits, Drawbacks, and Concrete Solutions

Blogs

Blogs
Health Industry Washington Watch

CMS Issues Proposed Rules to Impose International MFN Drug Pricing for Portion of Medicare Part B and D Utilization Under “GLOBE” and “GUARD” Models

Blogs
Health Industry Washington Watch

HHS Announces Crackdown on Health Data Blocking

Blogs
Health Industry Washington Watch

CMS Proposes Changes to Average Sales Price Calculations for Part B Drug Reimbursement

Blogs
Health Industry Washington Watch

CMS Launches WISeR Model to Target Waste by Leveraging (Broken) Prior Authorization System

Blogs
Health Industry Washington Watch

OIG Issues Unfavorable Opinion to Device Manufacturer

Blogs
Health Industry Washington Watch

OIG Issues Favorable Advisory Opinion 25-03 Regarding Telehealth Arrangement

Blogs
Health Industry Washington Watch

Elimination of the Richardson Waiver Means Changes . . . But To What End?

1 / 7